Skip to main content
. 2013 Jun 13;11:13. doi: 10.1186/1478-7547-11-13

Figure 4.

Figure 4

Contribution of clinical variables to median COPD cost. + variable present; - variable not present CAD-coronary artery disease; HTN-hypertension; COPD-chronic obstructive pulmonary disease; SAMA-short acting anti-muscarinic agonist; LAMA-long acting anti-muscarinic agonist; LABA-long acting beta agonist; ICS-inhaled corticosteroid.